Prostaglandin E2 Secreted by Thyroid Cancer Cells Contributes to Immune Escape Through the Suppression of Natural Killer (NK) Cell Cytotoxicity and NK Cell Differentiation

Natural killer (NK) cells play important roles in immune surveillance. However, the tumor microenvironment suppresses NK cell function and allows cancer cells to evade immune detection. In this study, we investigated whether the thyroid cancer cell microenvironment has this effect on NK cells. We fo...

Full description

Bibliographic Details
Main Authors: Arum Park, Yunhee Lee, Mi Sun Kim, Young Ju Kang, Young-Jun Park, Haiyoung Jung, Tae-Don Kim, Hee Gu Lee, Inpyo Choi, Suk Ran Yoon
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-08-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2018.01859/full
id doaj-3b032f0ea64c4ba78f35f52b49294f7d
record_format Article
spelling doaj-3b032f0ea64c4ba78f35f52b49294f7d2020-11-25T00:10:01ZengFrontiers Media S.A.Frontiers in Immunology1664-32242018-08-01910.3389/fimmu.2018.01859363999Prostaglandin E2 Secreted by Thyroid Cancer Cells Contributes to Immune Escape Through the Suppression of Natural Killer (NK) Cell Cytotoxicity and NK Cell DifferentiationArum Park0Arum Park1Yunhee Lee2Yunhee Lee3Mi Sun Kim4Young Ju Kang5Young-Jun Park6Young-Jun Park7Haiyoung Jung8Haiyoung Jung9Tae-Don Kim10Tae-Don Kim11Hee Gu Lee12Hee Gu Lee13Inpyo Choi14Inpyo Choi15Suk Ran Yoon16Suk Ran Yoon17Immunotherapy Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, South KoreaDepartment of Functional Genomics, University of Science & Technology, Daejeon, South KoreaImmunotherapy Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, South KoreaDepartment of Biochemistry, College of Pharmacy, Chungnam National University, Daejeon, South KoreaImmunotherapy Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, South KoreaNew Drug Development Center, OSONG Medical Innovation Foundation, Cheongju-si, South KoreaImmunotherapy Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, South KoreaDepartment of Functional Genomics, University of Science & Technology, Daejeon, South KoreaImmunotherapy Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, South KoreaDepartment of Functional Genomics, University of Science & Technology, Daejeon, South KoreaImmunotherapy Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, South KoreaDepartment of Functional Genomics, University of Science & Technology, Daejeon, South KoreaImmunotherapy Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, South KoreaDepartment of Functional Genomics, University of Science & Technology, Daejeon, South KoreaImmunotherapy Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, South KoreaDepartment of Functional Genomics, University of Science & Technology, Daejeon, South KoreaImmunotherapy Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, South KoreaDepartment of Functional Genomics, University of Science & Technology, Daejeon, South KoreaNatural killer (NK) cells play important roles in immune surveillance. However, the tumor microenvironment suppresses NK cell function and allows cancer cells to evade immune detection. In this study, we investigated whether the thyroid cancer cell microenvironment has this effect on NK cells. We found that prostaglandin (PG) E2 produced by thyroid cancer cells suppressed the cytolytic activity of NK cells by inhibiting the expression of the natural cytotoxicity receptors NKp44 and NKp30 and the death receptor tumor necrosis factor-related apoptosis-inducing ligand. PGE2 and cyclooxygenase-2 were highly expressed in thyroid cancer cells; moreover, anaplastic thyroid cancer cells released higher amounts of PGE2 than the papillary subtype, which was associated with suppression of NK cell-inducing nuclear factor-κB and mitogen-activated protein kinase/extracellular signal-regulated kinase pathways via PGE2 receptor (EP) 2 and EP4 expressed on the NK cell surface. In addition, PGE2 inhibited the functional maturation of NK cells and reduced their cytotoxicity against target cells. These results indicate that PGE2 promotes thyroid cancer progression by inhibiting NK cell maturation and cytotoxicity. Thus, therapeutic strategies that target PGE2 in thyroid cancer could potentiate the immune response and improve patient prognosis.https://www.frontiersin.org/article/10.3389/fimmu.2018.01859/fullprostaglandin E2thyroid cancernatural killer cellimmune escapecytotoxicitydifferentiation
collection DOAJ
language English
format Article
sources DOAJ
author Arum Park
Arum Park
Yunhee Lee
Yunhee Lee
Mi Sun Kim
Young Ju Kang
Young-Jun Park
Young-Jun Park
Haiyoung Jung
Haiyoung Jung
Tae-Don Kim
Tae-Don Kim
Hee Gu Lee
Hee Gu Lee
Inpyo Choi
Inpyo Choi
Suk Ran Yoon
Suk Ran Yoon
spellingShingle Arum Park
Arum Park
Yunhee Lee
Yunhee Lee
Mi Sun Kim
Young Ju Kang
Young-Jun Park
Young-Jun Park
Haiyoung Jung
Haiyoung Jung
Tae-Don Kim
Tae-Don Kim
Hee Gu Lee
Hee Gu Lee
Inpyo Choi
Inpyo Choi
Suk Ran Yoon
Suk Ran Yoon
Prostaglandin E2 Secreted by Thyroid Cancer Cells Contributes to Immune Escape Through the Suppression of Natural Killer (NK) Cell Cytotoxicity and NK Cell Differentiation
Frontiers in Immunology
prostaglandin E2
thyroid cancer
natural killer cell
immune escape
cytotoxicity
differentiation
author_facet Arum Park
Arum Park
Yunhee Lee
Yunhee Lee
Mi Sun Kim
Young Ju Kang
Young-Jun Park
Young-Jun Park
Haiyoung Jung
Haiyoung Jung
Tae-Don Kim
Tae-Don Kim
Hee Gu Lee
Hee Gu Lee
Inpyo Choi
Inpyo Choi
Suk Ran Yoon
Suk Ran Yoon
author_sort Arum Park
title Prostaglandin E2 Secreted by Thyroid Cancer Cells Contributes to Immune Escape Through the Suppression of Natural Killer (NK) Cell Cytotoxicity and NK Cell Differentiation
title_short Prostaglandin E2 Secreted by Thyroid Cancer Cells Contributes to Immune Escape Through the Suppression of Natural Killer (NK) Cell Cytotoxicity and NK Cell Differentiation
title_full Prostaglandin E2 Secreted by Thyroid Cancer Cells Contributes to Immune Escape Through the Suppression of Natural Killer (NK) Cell Cytotoxicity and NK Cell Differentiation
title_fullStr Prostaglandin E2 Secreted by Thyroid Cancer Cells Contributes to Immune Escape Through the Suppression of Natural Killer (NK) Cell Cytotoxicity and NK Cell Differentiation
title_full_unstemmed Prostaglandin E2 Secreted by Thyroid Cancer Cells Contributes to Immune Escape Through the Suppression of Natural Killer (NK) Cell Cytotoxicity and NK Cell Differentiation
title_sort prostaglandin e2 secreted by thyroid cancer cells contributes to immune escape through the suppression of natural killer (nk) cell cytotoxicity and nk cell differentiation
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2018-08-01
description Natural killer (NK) cells play important roles in immune surveillance. However, the tumor microenvironment suppresses NK cell function and allows cancer cells to evade immune detection. In this study, we investigated whether the thyroid cancer cell microenvironment has this effect on NK cells. We found that prostaglandin (PG) E2 produced by thyroid cancer cells suppressed the cytolytic activity of NK cells by inhibiting the expression of the natural cytotoxicity receptors NKp44 and NKp30 and the death receptor tumor necrosis factor-related apoptosis-inducing ligand. PGE2 and cyclooxygenase-2 were highly expressed in thyroid cancer cells; moreover, anaplastic thyroid cancer cells released higher amounts of PGE2 than the papillary subtype, which was associated with suppression of NK cell-inducing nuclear factor-κB and mitogen-activated protein kinase/extracellular signal-regulated kinase pathways via PGE2 receptor (EP) 2 and EP4 expressed on the NK cell surface. In addition, PGE2 inhibited the functional maturation of NK cells and reduced their cytotoxicity against target cells. These results indicate that PGE2 promotes thyroid cancer progression by inhibiting NK cell maturation and cytotoxicity. Thus, therapeutic strategies that target PGE2 in thyroid cancer could potentiate the immune response and improve patient prognosis.
topic prostaglandin E2
thyroid cancer
natural killer cell
immune escape
cytotoxicity
differentiation
url https://www.frontiersin.org/article/10.3389/fimmu.2018.01859/full
work_keys_str_mv AT arumpark prostaglandine2secretedbythyroidcancercellscontributestoimmuneescapethroughthesuppressionofnaturalkillernkcellcytotoxicityandnkcelldifferentiation
AT arumpark prostaglandine2secretedbythyroidcancercellscontributestoimmuneescapethroughthesuppressionofnaturalkillernkcellcytotoxicityandnkcelldifferentiation
AT yunheelee prostaglandine2secretedbythyroidcancercellscontributestoimmuneescapethroughthesuppressionofnaturalkillernkcellcytotoxicityandnkcelldifferentiation
AT yunheelee prostaglandine2secretedbythyroidcancercellscontributestoimmuneescapethroughthesuppressionofnaturalkillernkcellcytotoxicityandnkcelldifferentiation
AT misunkim prostaglandine2secretedbythyroidcancercellscontributestoimmuneescapethroughthesuppressionofnaturalkillernkcellcytotoxicityandnkcelldifferentiation
AT youngjukang prostaglandine2secretedbythyroidcancercellscontributestoimmuneescapethroughthesuppressionofnaturalkillernkcellcytotoxicityandnkcelldifferentiation
AT youngjunpark prostaglandine2secretedbythyroidcancercellscontributestoimmuneescapethroughthesuppressionofnaturalkillernkcellcytotoxicityandnkcelldifferentiation
AT youngjunpark prostaglandine2secretedbythyroidcancercellscontributestoimmuneescapethroughthesuppressionofnaturalkillernkcellcytotoxicityandnkcelldifferentiation
AT haiyoungjung prostaglandine2secretedbythyroidcancercellscontributestoimmuneescapethroughthesuppressionofnaturalkillernkcellcytotoxicityandnkcelldifferentiation
AT haiyoungjung prostaglandine2secretedbythyroidcancercellscontributestoimmuneescapethroughthesuppressionofnaturalkillernkcellcytotoxicityandnkcelldifferentiation
AT taedonkim prostaglandine2secretedbythyroidcancercellscontributestoimmuneescapethroughthesuppressionofnaturalkillernkcellcytotoxicityandnkcelldifferentiation
AT taedonkim prostaglandine2secretedbythyroidcancercellscontributestoimmuneescapethroughthesuppressionofnaturalkillernkcellcytotoxicityandnkcelldifferentiation
AT heegulee prostaglandine2secretedbythyroidcancercellscontributestoimmuneescapethroughthesuppressionofnaturalkillernkcellcytotoxicityandnkcelldifferentiation
AT heegulee prostaglandine2secretedbythyroidcancercellscontributestoimmuneescapethroughthesuppressionofnaturalkillernkcellcytotoxicityandnkcelldifferentiation
AT inpyochoi prostaglandine2secretedbythyroidcancercellscontributestoimmuneescapethroughthesuppressionofnaturalkillernkcellcytotoxicityandnkcelldifferentiation
AT inpyochoi prostaglandine2secretedbythyroidcancercellscontributestoimmuneescapethroughthesuppressionofnaturalkillernkcellcytotoxicityandnkcelldifferentiation
AT sukranyoon prostaglandine2secretedbythyroidcancercellscontributestoimmuneescapethroughthesuppressionofnaturalkillernkcellcytotoxicityandnkcelldifferentiation
AT sukranyoon prostaglandine2secretedbythyroidcancercellscontributestoimmuneescapethroughthesuppressionofnaturalkillernkcellcytotoxicityandnkcelldifferentiation
_version_ 1725409589433729024